生物保存市场规模、份额和成长分析（按产品、生物样本、应用、最终用户和地区）- 产业预测 2025-2032

2023 年全球生物保存市场规模为 28 亿美元，预计将从 2024 年的 35.9 亿美元成长到 2032 年的 263.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 28.3%。

由于技术进步以及对生物质和生物产品（包括 DNA、组织和干细胞）保存的需求不断增加，生物保存市场正在经历显着增长。微阵列和预测模型整合等最新技术创新正在简化生物保存过程，减少时间、成本和复杂性。此外，多路復用细胞成像平台正在增强生物保存能力并促进其在心臟病学和妇科等专业的应用。随着慢性病的增加，人们对开发免疫疗法和疫苗等生物解决方案的兴趣日益浓厚，进一步推动了对生物保存的需求。此外，公私合作也有助于资助研发计划，而医疗保健支出的增加预计将在未来几年推动市场持续扩张。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析

生物保存市场规模（按产品）

• 市场概况
• 生物保存介质
  • 冷冻保存介质
  • 冷冻保存介质
• 生物保鲜设备
  • 温度控制系统
  • 冷冻库
  • 低温储存系统
  • 除霜装置
  • 冰箱
  • 警报及监控系统
  • 培养箱
  • 离心机
  • 其他生物保鲜设备
• 生物保存配件

生物保存市场规模（依生物样本）

• 市场概况
• 人体组织样本
• 器官
• 干细胞
• 其他生物标本

生物保存市场规模（按应用）

• 市场概况
• 研究用途
• 治疗用途
• 其他用途

生物保存市场规模（按最终用户划分）

• 市场概况
• 生物库
• 基因库
• 医院
• 其他最终用户

生物保存市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（United States）
• Merck KGaA（Germany）
• BioLife Solutions, Inc.（United States）
• STEMCELL Technologies（Canada）
• Helmer Scientific Inc.（United States）
• PrincetonCryo（United States）
• OPS Diagnostics（United States）
• ThermoGenesis Holdings, Inc.（United States）
• Avantor, Inc.（United States）
• Bio-Techne Corporation（United States）
• Exact Sciences Corporation（United States）
• Worthington Industries, Inc.（United States）
• Chart Industries, Inc.（United States）
• Azenta US, Inc.（United States）
• LabVantage Solutions, Inc.（United States）
• Qiagen NV（Netherlands）
• Taylor-Wharton Cryogenics LLC（United States）
• PHC Holdings Corporation（Japan）
• Panasonic Corporation（Japan）
• Lifeline Scientific, Inc.（United States）

结论和建议

Global Biopreservation Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.59 billion in 2024 to USD 26.38 billion by 2032, growing at a CAGR of 28.3% during the forecast period (2025-2032).

The biopreservation market is experiencing notable growth, driven by advancements in technology and an increasing demand for the preservation of biomass and biological products, including DNA, tissues, and stem cells. Recent innovations, such as microarrays and predictive modeling integration, have streamlined the biopreservation process, reducing time, costs, and complexity. Additionally, multiplex cellular imaging platforms enhance biopreservation capabilities, fostering adoption in specialties like cardiology and gynecology. With a rise in chronic diseases, there's heightened interest in developing biological solutions such as immunotherapies and vaccines, further propelling biopreservation demand. Collaborations between public and private sectors are also boosting funding for R&D initiatives, while growing healthcare expenditures are expected to drive continued market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopreservation Market Segments Analysis

Global Biopreservation Market is segmented by Product, Biospecimen, Application, End User and region. Based on Product, the market is segmented into Biopreservation Media, Biopreservation Equipment and Biopreservation Accessories. Based on Biospecimen, the market is segmented into Human Tissue Samples, Organs, Stem Cells and Other Biospecimens. Based on Application, the market is segmented into Research Applications, Therapeutic Applications, Other Applications. Based on End User, the market is segmented into Biobanks, Gene Banks, Hospitals and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopreservation Market

The Global Biopreservation market is significantly driven by the increasing prevalence of chronic diseases worldwide. In developed nations like the United States, over 30% of adults are reported to be affected by these conditions annually, while in developing countries such as India, the figure exceeds 23%. The growing number of chronic disease cases necessitates enhanced diagnostic methods and alternative therapies, which consequently heightens the demand for biopreservation solutions. As healthcare systems strive to manage these diseases effectively, the need for innovative biopreservation techniques to safeguard biological materials becomes essential, further propelling the growth of this market.

Restraints in the Global Biopreservation Market

The Global Biopreservation market faces several restraints primarily revolving around the management of vital environmental factors such as temperature, pressure, and pH, essential for maintaining biomass stability during storage. Achieving effective biopreservation necessitates the use of advanced equipment, specialized consumables, media solutions, and trained personnel, all of which can contribute to elevated costs. Moreover, certain consumables exhibit significant instability and are not readily accessible in the market, further complicating the situation. The substantial initial investment required for setting up biopreservation infrastructure poses a barrier to broader applications across various sectors, limiting the market's overall expansion and accessibility.

Market Trends of the Global Biopreservation Market

The Global Biopreservation market is poised for significant growth, driven by the escalating demand for cell therapy and genetic engineering, anticipated to surge at over 30% CAGR during the forecast period. This trend is catalyzing increased investments from biomedical firms in research and development, as innovative cell and gene therapies revolutionize the diagnosis and treatment of severe and chronic health conditions. Additionally, rising government funding for research centers dedicated to gene therapy and regenerative medicine underscores a robust commitment to advancing these technologies. This confluence of factors positions the biopreservation sector as a crucial player in the future of healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Biopreservation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Biopreservation Media
  • Cryopreservation Media
  • Hypothermic Preservation Media
• Biopreservation Equipment
  • Temperature Control Systems
  • Freezers
  • Cryogenic Storage Systems
  • Thawing Equipment
  • Refrigerators
  • Alarm Monitoring Systems
  • Incubators
  • Centrifuges
  • Other Biopreservation Equipment
• Biopreservation Accessories

Global Biopreservation Market Size by Biospecimen & CAGR (2025-2032)

• Market Overview
• Human Tissue Samples
• Organs
• Stem Cells
• Other Biospecimens

Global Biopreservation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research Applications
• Therapeutic Applications
• Other Applications

Global Biopreservation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biobanks
• Gene Banks
• Hospitals
• Other End Users

Global Biopreservation Market Size & CAGR (2025-2032)

• North America (Product, Biospecimen, Application, End User)
  • US
  • Canada
• Europe (Product, Biospecimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Biospecimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Biospecimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Biospecimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helmer Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PrincetonCryo (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OPS Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoGenesis Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worthington Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chart Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta US, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabVantage Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taylor-Wharton Cryogenics LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panasonic Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeline Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations